Clinical Trial Update: Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update comparing psilocybin with pimavanserin versus psilocybin alone for major depressive disorder; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Pimavanserin (pimavanserin)
• Psilocybin (psilocybin)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Major Depressive Disorder | Phase 2 | Status: RECRUITING